CVS Corp (CVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,239,000 | 4,644,000 | 4,592,000 | 3,862,000 | 3,458,000 |
| Depreciation Amortization | 2,092,000 | 1,931,000 | 1,870,000 | 1,753,000 | 1,568,000 |
| Income taxes - deferred | -252,000 | -58,000 | -86,000 | -111,000 | 144,000 |
| Accounts receivable | -1,594,000 | -737,000 | -2,210,000 | -387,000 | -748,000 |
| Accounts payable and accrued liabilities | 2,834,000 | 1,742,000 | 1,024,000 | 1,147,000 | 1,128,000 |
| Other Working Capital | 1,244,000 | 934,000 | -734,000 | 687,000 | 604,000 |
| Other Operating Activity | -1,024,000 | -319,000 | 1,327,000 | -280,000 | -298,000 |
| Operating Cash Flow | $8,539,000 | $8,137,000 | $5,783,000 | $6,671,000 | $5,856,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -267,000 | 4,000 | -90,000 | 0 | 57,000 |
| PPE Investments | -2,332,000 | -2,125,000 | -1,930,000 | -2,007,000 | -1,868,000 |
| Net Acquisitions | -11,475,000 | -2,439,000 | -415,000 | -371,000 | -1,191,000 |
| Sale Of Investment | 243,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 411,000 | 515,000 | 600,000 | 529,000 | 592,000 |
| Investing Cash Flow | $-13,420,000 | $-4,045,000 | $-1,835,000 | $-1,849,000 | $-2,410,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -685,000 | 685,000 | -690,000 | -60,000 | 450,000 |
| Debt Issued | 14,805,000 | 1,483,000 | 3,964,000 | 1,239,000 | 1,463,000 |
| Debt Repayment | -2,902,000 | -3,100,000 | 0 | -1,718,000 | -2,122,000 |
| Common Stock Issued | 362,000 | 421,000 | 500,000 | 836,000 | 431,000 |
| Common Stock Repurchased | -5,001,000 | -4,001,000 | -3,976,000 | -4,330,000 | -3,001,000 |
| Dividend Paid | -1,576,000 | -1,288,000 | -1,097,000 | -829,000 | -674,000 |
| Other Financing Activity | -124,000 | 106,000 | 62,000 | 2,000 | -7,000 |
| Financing Cash Flow | $4,879,000 | $-5,694,000 | $-1,237,000 | $-4,860,000 | $-3,460,000 |
| Exchange Rate Effect | -20,000 | -6,000 | 3,000 | 0 | 0 |
| Beginning Cash Position | 2,481,000 | 4,089,000 | 1,375,000 | 1,413,000 | 1,427,000 |
| End Cash Position | 2,459,000 | 2,481,000 | 4,089,000 | 1,375,000 | 1,413,000 |
| Net Cash Flow | $-22,000 | $-1,608,000 | $2,714,000 | $-38,000 | $-14,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,539,000 | 8,137,000 | 5,783,000 | 6,671,000 | 5,856,000 |
| Capital Expenditure | -2,367,000 | -2,136,000 | -1,984,000 | -2,030,000 | -1,872,000 |
| Free Cash Flow | 6,172,000 | 6,001,000 | 3,799,000 | 4,641,000 | 3,984,000 |